amikacin has been researched along with clarithromycin in 168 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 31 (18.45) | 18.2507 |
| 2000's | 49 (29.17) | 29.6817 |
| 2010's | 59 (35.12) | 24.3611 |
| 2020's | 29 (17.26) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, SH; Franzblau, SG; Hwang, CH; Pauli, GF; Wan, B; Warit, S | 1 |
| Baudry, PJ; DeCorby, M; Hoban, DJ; Johnson, J; Karlowsky, JA; Lagacé-Wiens, P; Laing, N; McCracken, M; Mulvey, MR; Nichol, KA; Tailor, F; Vashisht, R; Walkty, A; Weshnoweski, B; Wierzbowski, A; Zhanel, GG | 1 |
| Byrd, TF; Greendyke, R | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Esteban, J; Fernández-Martínez, AI; Fernández-Roblas, R; Gadea, I; García-Almeida, D; Martín-de-Hijas, NZ | 1 |
| Connell, TG; Curtis, N; Ritz, N; Robins-Browne, R; Sievers, A; Tebruegge, M | 1 |
| Andries, K; Gevers, T; Lounis, N; Van den Berg, J; Vranckx, L | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Glen, RC; Lowe, R; Mitchell, JB | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Ashenden, S; Bender, A; Cokol, M; Karakoc, I; Kuru, N; Mason, DJ; Meral, S; Stott, I; Weinstein, ZB | 1 |
| Cynamon, MH; DeStefano, MS; Klemens, SP | 1 |
| Cynamon, MH; Klemens, SP; Swenson, CE | 1 |
| Caccamo, F; de Lalla, F; Marone, P; Maserati, R; Nicolin, R; Rigoli, R; Scarpellini, P | 1 |
| De Gregoris, P; Fattorini, L; Hu, CQ; Iona, E; Mascellino, MT; Orefici, G; Santoro, C | 1 |
| Brink, AJ; Koornhof, HJ; Widgerow, AD | 1 |
| Michałowska-Mitczuk, D | 1 |
| Grosset, J; Ji, B; Lounis, N; Truffot-Pernot, C | 2 |
| Fattorini, L; Li, B; Orefici, G; Piersimoni, C; Ricci, ML; Santoro, C; Tortoli, E; Xiao, Y | 1 |
| Bollet, C; de Micco, P; Gevaudan, MJ | 1 |
| Berlin, OG; Bruckner, DA; Helm, CJ; Holland, GN; Lin, R | 1 |
| Hjelm, U; Hoffner, SE; Källenius, G | 1 |
| Garces, MC; Liening, DA; McAllister, CK; Plemmons, RM | 1 |
| Coker, RJ; Fisher, M; Tomlinson, DR | 1 |
| Barbeau, P; Lapeyre, C; Leng, B; Maugein, J; Pellegrin, I; Pellegrin, JL | 1 |
| Fuursted, K | 1 |
| Barbarini, D; Bono, L; Carretto, E; Marone, P; Telecco, S | 1 |
| Brancato, R; Carones, F; Cavallero, A; Gesu, G; Venturi, E | 1 |
| Clumeck, N; De Wit, S; Payen, MC | 1 |
| Creti, R; Fattorini, L; Iona, E; Li, Y; Mattei, M; Orefici, G; Ricci, ML; Thoresen, OF; Xiao, Y | 1 |
| Koster, F | 1 |
| Carton, AT; Kerawala, CJ; Makhani, S; Postlethwaite, KR; Renny, NM | 1 |
| Horgen, L; Legrand, E; Rastogi, N | 2 |
| Horgen, L; Jerome, A; Rastogi, N | 1 |
| Ansorg, R; Fabry, W; Schmid, EN | 1 |
| Kerharo, G; Matsiota-Bernard, P; Nauciel, C; Vrioni, G | 1 |
| Bergmann, JS; Boulet, B; Brown, BA; Fahle, GA; Plaunt, M; Wallace, RJ; Wanger, A; Witebsky, FG; Woods, GL | 1 |
| Dart, JK; Horgan, SE; Matheson, MM; McLOUGHLIN-Borlace, L | 1 |
| Fattorini, L; Iona, E; Li, Y; Mattei, M; Orefici, G; Thoresen, OF; Xiao, Y | 1 |
| Colin, AA | 1 |
| Edson, RS; Mueller, PS | 1 |
| Harada, M; Kataoka, M; Kawata, N; Matsuo, K; Nabe, M; Okamoto, M; Tada, S; Takeuchi, M; Yamadori, I | 1 |
| Cabras, AD; Höfler, H; Kremer, M; Lügering, A; Schulz, S; Seidel, M; Werner, M | 1 |
| Miller, SD | 1 |
| Alvarez-Elcoro, S; Chu, SY; Hellinger, WC; Maniu, CV; Palmer, R | 1 |
| Culbertson, WW; Dubovy, SR; Huang, AJ; Karp, CL; Miller, D; Solomon, A | 1 |
| Báñez, F; Biechy, M; Gálvez, E; Salgueró, E | 1 |
| Giaconi, J; Pham, R; Ta, CN | 1 |
| Bentoucha, A; Dega, H; Grosset, J; Jarlier, V; Robert, J | 1 |
| Dailloux, M; Dauendorffer, JN; Laurain, C; Weber, M | 1 |
| Cabria, F; Esteban, J; Fernández-Roblas, R; Gadea, I; Rollan, E; Santos-O'Connor, FG; Soriano, F; Torres, MV | 1 |
| Daines, BS; Sandoval, HP; Solomon, KD; Steed, LL; Vroman, DT | 1 |
| Forslöw, U; Geborek, A; Heurlin, N; Hjelte, L; Petrini, B | 1 |
| Baba, T; Ikehara, K; Ishigatsubo, Y; Kaneko, T; Kusano, N; Nishiyama, H; Shinohara, T; Shoji, A; Suzuki, S; Tagawa, A; Tsuburai, T | 1 |
| Alvirez-Freites, E; Cynamon, MH; DeStefano, MS; Yeo, AE | 1 |
| Li, GX; Lian, CH; Lin, Z; Liu, SX; Weng, KR; Wu, RS; Wu, WH | 1 |
| Dick, JD; Hose, S; Hyon, JY; Joo, MJ; O'Brien, TP; Sinha, D | 1 |
| Kasai, S; Nishiyama, H; Tokuda, H; Yoshikawa, M | 1 |
| Cohen, EJ; Mah-Sadorra, JH; Rapuano, CJ | 1 |
| Antonopoulou, A; Baziaka, F; Giamarellos-Bourboulis, EJ; Giamarellou, H; Kousoulas, V; Koutoukas, P; Panagou, C; Perrea, D; Sabracos, L | 1 |
| Adamis, T; Baziaka, F; Giamarellos-Bourboulis, E; Giamarellou, H; Karayannacos, P; Koutoukas, P; Plachouras, D; Raftogiannis, M; Sabracos, L; Tsaganos, T | 1 |
| Jeyaratnam, D; Keenan, N; Sheerin, NS | 1 |
| Bakker-Woudenberg, IA; van Agtmael, MA; van Soolingen, D; van Vianen, W; Verbrugh, HA | 1 |
| Bar, T; Lewkowicz, A; Mishal, J; Nahlieli, O | 1 |
| Hasegawa, A; Ito, M; Kano, R; Kashima, M; Mikami, Y; Mizoguchi, M; Takahama, H | 1 |
| Chimara, E; da Silva Telles, MA; Ferrazoli, L; Riley, LW | 1 |
| Kim, WJ; Oh, CH; Ryu, HJ; Song, HJ | 1 |
| Adamis, T; Antonopoulou, A; Giamarellos-Bourboulis, EJ; Giamarellou, H; Koutoukas, P; Panagou, C; Raftogiannis, M; Tsaganos, T; Tziortzioti, V | 1 |
| Appelgren, P; Farnebo, F; Hedblad, MA; Petrini, B | 1 |
| Haddad, R; Hamam, RN; Khoury, JM; Noureddin, B; Salti, HI | 1 |
| Petrini, B | 1 |
| De Freitas, D; Hofling-Lima, AL; Matieli, LC; Moraes, NS; Sampaio, J; Yu, MC | 1 |
| Jackson, MA; Selvarangan, R; Sharma, M; Thorell, EA; Woods, GM | 1 |
| Brumble, L; Garland, JL; Johnson, MM; Khoor, A; Roy, A; Waller, EA | 1 |
| Kamio, Y; Kimura, S; Kuriu, K; Nakajima, H; Shibuya, Y; Shikama, Y | 1 |
| Bakker-Woudenberg, IA; de Steenwinkel, JE; Schiffelers, RM; Ten Kate, MT; van Agtmael, MA; van Vianen, W; Verbrugh, HA | 1 |
| Espandar, L; Meyer, JJ; Moshirfar, M | 1 |
| Fujii, H; Goto, H; Ikezawa, Z; Inayama, Y; Ito, S; Kajiwara, R; Kuroki, F; Shigehira, Y; Taniguchi, A; Yanagimachi, M; Yokosuka, T; Yokota, S | 1 |
| Jeon, K; Kim, BJ; Kim, CK; Koh, WJ; Kook, YH; Kwon, OJ; Lee, NY; Lee, SH; Park, YK | 1 |
| Gutiérrez-de la Peña, J; Martín-Santiago, A; Montis-Suau, A; Ruiz-Veramendi, M | 1 |
| Chang, KM; Chu, SH; Lee, HC; Shyur, SD; Wu, YL | 1 |
| Ali-Dinar, T; Colin, AA | 1 |
| Daley, CL; Huitt, GA; Jeon, K; Kim, BJ; Kim, CK; Koh, WJ; Kook, YH; Kwon, OJ; Lee, NY; Lee, SH; Park, YK; Shin, SJ | 1 |
| Bae, SM; Cheong, HJ; Choi, WS; Kim, MJ; Park, DW; Sohn, JW; Son, SW; Song, T; Yoon, YK | 1 |
| Huang, YC; Kao, CC; Lin, CF; Liu, MF; Liu, PY; Shen, GH; Shi, ZY | 1 |
| Alonso-Rodríguez, N; Esteban, J; Fernández-Roblas, R; Martín-de-Hijas, N; Molina-Manso, D; Ortíz-Pérez, A | 1 |
| Brescini, L; Cirioni, O; Gabrielli, E; Ghiselli, R; Giacometti, A; Guerrieri, M; Minardi, D; Muzzonigro, G; Orlando, F; Rimini, M; Silvestri, C | 1 |
| Hsieh, CJ; Hsueh, PR; Hwang, KP; Kuo, KC | 1 |
| Atassi, K; Bassinet, L; Honoré, I; Housset, B; Jabot, L; Maître, B; Mangiapan, G; Monnet, I; Schubel, K | 1 |
| Girgis, DO; Karp, CL; Miller, D | 1 |
| Ankomah, P; Levin, BR | 1 |
| Bensira, L; Domany, KA; Glatstein, M; Scolnik, D; Shah, M; Vala, S | 1 |
| Aarnoutse, RE; Boeree, MJ; Daley, CL; Egelund, EF; Heifets, LB; Levin, A; Mouton, JW; Peloquin, CA; Totten, SE; van Ingen, J | 1 |
| Borole, AJ; Chilgar, RM; D'Silva, JA; Thomas, M | 1 |
| Chen, JH; Hu, ST; Huang, CC; Huang, CW; Huang, WC; Lee, YC; Shen, GH | 1 |
| Carter, ER; Iwanaga, K | 1 |
| Cai, L; Li, CY; Liu, ZH; Sun, ZG; Zhang, JZ; Zhou, C; Zhuo, FL | 1 |
| Chen, PR; Tan, SY | 1 |
| Banerjee, P; Dogra, V; Haider, M; Husain, J; Jaggi, T; Loomba, P; Mishra, B; Thakur, A | 1 |
| Gui, J; Hong, CY; Li, JL; Liang, J; Wang, F | 1 |
| Gotoh, M; Katagiri, S; Nakamura, I; Ohyashiki, K; Yoshizawa, S | 1 |
| Fowler, J; Mahlen, SD | 1 |
| Chu, N; Duan, H; Huang, H; Lu, Y; Nie, W | 1 |
| Bernard, C; Galati, E; Jarlier, V; Renvoisé, A; Robert, J; Veziris, N | 1 |
| Chang, SC; Chu, HS; Hu, FR; Shen, EP | 1 |
| Baqai, J; Hong, AR; Huang, AJ; Lubniewski, AJ; Nguyen, AT | 1 |
| Matsumoto, T; Otsuka, K; Tomii, K | 1 |
| Ferro, BE; Mouton, JW; van Ingen, J; van Soolingen, D; Wattenberg, M | 1 |
| Esteban, J; García-Pedrazuela, M; Mahillo-Fernandez, I; Muñoz-Egea, MC | 1 |
| Aubry, A; Bernard, C; Brossier, F; Cambau, E; Galati, E; Jarlier, V; Renvoisé, A; Robert, J; Sougakoff, W; Veziris, N | 1 |
| Adderson, EE; Apiwattankul, N; Flynn, PM; Hayden, RT | 1 |
| Hashiguchi, N; Inoshima, I; Inoshima, N | 1 |
| Akiyama, M; Betsuyaku, T; Hasegawa, N; Ishii, M; Kohno, M; Namkoong, H; Suzuki, K; Takeuchi, T; Tasaka, S; Yagi, K | 1 |
| de Jong, A; Ferro, BE; Meletiadis, J; Mouton, JW; van Ingen, J; van Soolingen, D; Wattenberg, M | 1 |
| Frew, JW; Nguyen, RT | 1 |
| Cengiz, AB; Emiralioğlu, N; Ersöz, DD; Kiper, N; Oğuz, B; Özçelik, U; Özsürekçi, Y; Saribas, Z; Yalçın, E | 1 |
| Shah, VA; Siatkowski, RL; Sluch, IM | 1 |
| Burillo-Martínez, S; Garrido-Ruiz, MC; Maroñas-Jiménez, L; Morales, E; Rodríguez-Peralto, JL | 1 |
| Deshpande, D; Ferro, BE; Gumbo, T; Mouton, JW; Pasipanodya, JG; Srivastava, S; van Ingen, J; van Soolingen, D | 1 |
| Bouziane, F; Cambau, E; Chau, F; Crockett, F; Mougari, F; Nessar, R; Raskine, L; Sapriel, G; Veziris, N | 1 |
| Burian, J; Kuchinski, K; Pryjma, M; Thompson, CJ | 1 |
| Chen, NY; Chiu, CH; Chung, WH; Kuo, AJ; Lai, HC; Lee, MC; Liu, TP; Lu, JJ; Sun, PL; Wang, LH; Wu, TL; Wu, TS; Yang, CH; Yang, JH | 1 |
| Arthur, M; Compain, F; Dorchène, D; Dubée, V; Gaillard, JL; Herrmann, JL; Heym, B; Soroka, D | 1 |
| Kim, EK; Kim, SK; Kim, TI; Ko, J; Yong, DE | 1 |
| Coenye, T; Crabbé, A; Esteban, J; Mahíllo-Fernández, I; Ostyn, L; Peremarch, CP; Rigauts, C; Rodríguez-Sevilla, G; Vandeplassche, E | 1 |
| Allyn, J; Andre, M; Belmonte, O; Coolen-Allou, N; Gazaille, V; Payet, A; Picot, S; Touron, T; Veziris, N | 1 |
| Baba, S; Fukuoka, K; Horikoshi, Y; Kamada, K; Kanemaru, A; Kikuchi, K; Myojin, S; Okamoto, Y; Suzuki, H; Yoshida, A | 1 |
| Chen, WL; Chu, HS; Hu, FR; Liu, HY; Wang, IJ | 1 |
| Liu, D; Lu, J; Ni, X; Song, Y; Wang, S; Zhao, Y; Zheng, H | 1 |
| Ananta, P; Chaimanee, P; Chetchotisakd, P; Faksri, K; Kham-Ngam, I; Lulitanond, V; Namwat, W; Reechaipichitkul, W | 1 |
| Andersen, ÅB; Gynthersen, R; Katzenstein, TL; Qvist, T | 1 |
| Almeida da Silva, PE; Bierhals, D; Lourenço, MC; Ramis, IB; Ramos, DF; Vianna, JS; Viveiros, M; von Groll, A; Zanatta, N | 1 |
| Chen, CL; Chen, CY; Chen, PL; Hsu, SM; Huang, FC; Hung, JH; Jou-Chen Huang, E; Ko, WC; Lai, CC; Lai, CH; Lin, SH; Teng, YT; Tseng, SH; Wang, SH; Wu, CL | 1 |
| Dalcolmo, MP; Daley, CL; Eather, G; Gayoso, R; Hasegawa, N; Jhun, BW; Koh, WJ; Kwak, N; Namkoong, H; Park, J; Thomson, R; van Ingen, J; Yim, JJ; Zweijpfenning, SMH | 1 |
| Costa, AFP; Farias Filho, FT; Laudelino, JS; Santos, VM | 1 |
| Jevert-Eichorn, S; Radigan, A | 1 |
| Fukui, M; Marumo, S; Shirata, M; Tamai, K; Yoshimoto, Y | 1 |
| Chang, CL; Chen, LC; Chien, JY; Hsueh, PR; Yu, CJ | 1 |
| Bañuls, AL; Bemer, P; Bertolotti, T; Bouzinbi, N; Chiron, R; Fangous, MS; Godreuil, S; Guet-Revillet, H; Héry-Arnaud, G; Marcy, O; Ouedraogo, AS; Pestel-Caron, M; Peuchant, O | 1 |
| Chonan, M; Fujimoto, Y; Ihara, H; Iwai, M; Kurokawa, K; Misawa, S; Nakamura, A; Ochi, Y; Ohsaka, A; Okabe, T; Shibayama, K; Sumiyoshi, I; Takahashi, K; Takei, S; Togo, S; Watanabe, J | 1 |
| Abbass, A; Dzudzor, B; Gyamfi, E; Mosi, L; Narh, CA; Quaye, C | 1 |
| Bonet-Rossinyol, Q; Fernández-Pittol, M; Gonzalez-Martin, J; López-Gavín, A; Portell-Buj, E; Roman, A; Tudó, G | 1 |
| Aljishi, A; Alwazzeh, MJ; Kristjansson, M | 1 |
| Khandelwal, S; Malhotra, B; Sharma, M | 1 |
| Aslan, AT; Deniz, M; Ramaslı Gursoy, T; Tapısız, A; Tezer, H | 1 |
| Arai, Y; Iguchi, S; Kamada, K; Kikuchi, K; Konno, S; Shimojima, M; Uzawa, Y; Yoshida, A | 1 |
| Garner, OB; Mirasol, R; Realegeno, S; Yang, S | 1 |
| Alcaraz, M; Illouz, M; Kremer, L; Roquet-Banères, F | 1 |
| Li, H; Li, S; Mulati, G; Pang, Y; Ren, W; Shang, Y; Wang, Y; Xue, Z; Yao, C | 1 |
| He, W; Li, Y; Liu, C; Ma, A; Qiu, Q; Zhao, Y | 1 |
| Chen, J; Chen, X; Hua, W; Lin, S; Liu, H; Shao, L; Wang, S; Zhang, W; Zhang, Y | 1 |
| Daneshfar, S; Hashemzadeh, M; Khosravi, AD | 1 |
| Chhaya, N; Koo, EH; Miller, D; Shaik, N; Tonk, RS; Weiss, M; Zhu, A | 1 |
| Ammerman, NC; Bax, HI; de Steenwinkel, JEM; de Vogel, CP; Mudde, SE; Schildkraut, JA; van Ingen, J | 1 |
| A Katouah, H; Acker, M; Al Hadi, R; Ali, M; Alserihi, R; Alyami, J; Alzahrani, E; Amirazodi, M; Amrillah, T; Andreassen, OA; Ardiccioni, C; Ask, H; Atzori, C; Ayorech, Z; Azambuja, JH; Azmi, R; Badem, S; Balci, AB; Bali, H; Baranova, NS; Barantsevich, ER; Barocci, S; Bauer, RJ; Bauermeister, JA; Bazhenova, TA; Biagetti, G; Bigdeli, F; Bonar, EE; Bouloumis, T; Bu, Y; Cai, Z; Cakiroglu, B; Canetto, SS; Cao, J; Caucci, S; Cerbo, I; Chen, C; Chen, J; Chen, Q; Chen, Y; Cheng, B; Cheng, X; Chinappi, M; Choya, A; Cicconardi, F; Cipolletta, S; Colasurdo, G; Costabile, BK; Coughlin, LN; Crippa, P; D'Agostino, M; D'Annessa, I; Daryanoosh, F; Das, R; Davey Smith, G; Davidson, BR; Davies, NM; Davis, TME; Davis, WA; de Rivas, B; Demir, D; Deng, Z; Dhanya, TM; Di Marino, D; Divya, KM; Dong, N; Drinkwater, JJ; Ekholuenetale, M; El-Bindary, AA; El-Bindary, MA; El-Desouky, MG; Elsayed, H; Ema, K; Endraswari, PD; Entilli, L; Ettl, T; Eyado, A; Fan, X; Fang, W; Farina, M; Florimbio, AR; Fowobaje, KR; Gaeini, A; Gao, XM; Gao, Y; Ghaemi, R; Ghelardi, E; Gilmutdinov, IF; Gochicoa-Rangel, L; Goncu, MT; Gözüküçük, R; Grammatikopoulos, P; Gu, Y; Guan, ZJ; Gucu, A; Guldberg, R; Gungor, O; Guo, W; Gutiérrez-Ortiz, JI; Guzmán-Boulloud, N; Guzmán-Valderrábano, C; Głuszko, A; Hama, A; Hamada, M; Han, J; Hashimoto, T; Havdahl, A; Hayashita, T; He, X; Helgeland, Ø; Hinck, AP; Hinck, CS; Holtzapple, M; Hou, Y; Howe, LD; Hu, B; Hu, H; Huang, L; Huang, Z; Hughes, AM; Hussain, G; Ibidoja, OJ; Ichikawa, D; Imber, C; Islam, MR; Iype, S; Jaber, J; Jacobs, R; Jafry, AT; Ji, L; Ji, X; Jiang, L; Jiang, Y; Jie, HFM; Jie, HM; Johansen, MP; Johansson, S; Juan, LX; Juan, W; Kahraman, N; Kallinger, I; Kang, H; Karakulova, YV; Kärmer, T; Kataoka, S; Kato, K; Kawashima, N; Kazim, AH; Khalil, MR; Kitazawa, H; Klimesova, YM; Kojima, S; Kose, M; Kostakis, ID; Koushkie Jahromi, M; Krishna, GA; Krizova, D; La Teana, A; Lan, K; Li, J; Li, JZ; Li, M; Li, R; Li, S; Li, Y; Li, Z; Liu, H; Liu, J; Liu, KG; Liu, L; Liu, Q; Liu, T; Liu, X; Lomachenko, KA; López-Fonseca, R; Ludwig, N; Luo, A; Luo, L; Luo, Y; Lupetti, A; M El-Metwaly, N; Ma, K; Maemura, R; Magnus, P; Manakin, YV; Mancia, F; Mashood, LO; Matsumoto, K; Mehrabi, A; Meier, JK; Mekonnen, Y; Mencarelli, D; Menzo, S; Mikagi, A; Mironov, VS; Misawa-Suzuki, T; Miwata, S; Mizuta, Y; Mohanan, PV; Mondal, J; Morici, P; Morita, K; Morozzo Della Rocca, B; Morris, T; Morsali, A; Morzhukhina, MV; Motta, S; Muramatsu, H; Naidu, R; Narita, A; Narita, K; Nasralla, D; Nemcokova, M; Netukova, M; Nishikawa, E; Nishio, N; Niu, X; Niu, Y; Njølstad, P; Notarstefano, V; Nugroho, MA; Nørgård, BM; Okuno, Y; Olokede, O; Ong, SP; Osailan, A; Ouyang, Z; Ozyazicioglu, AF; Pan, F; Parui, A; Paul, R; Pavoni, E; Payne, TE; Peng, X; Pérez-Padilla, R; Perta, N; Peter, SC; Pierantoni, L; Pietrowska, M; Pissanou, T; Pollok, JM; Prasetio, A; Putra, FS; Qiang, C; Qiao, L; Qutob, HMH; Raptis, DA; Razzo, BM; Reichborn-Kjennerud, T; Reichert, TE; Remigio-Luna, A; Rexha, J; Rivani, E; Rizzato, C; Romagnoli, A; Rossolini, GM; Sa, LY; Saad, RA; Sakaguchi, H; Salesi, M; Salsabilla, Z; Sanderson, E; Sanderson, P; Savitha, DP; Schulz, D; Seker, IB; Selvaganapathy, PR; Sha, D; Shah, SF; Shaikhomar, OA; Sharma, D; Shi, C; Shi, P; Shrotri, A; Sidiq, DH; Simonov, SV; Singh, AK; Song, C; Song, T; Spanier, G; Spoerl, S; Staropoli, A; Statsenko, ME; Steinhauer, S; Stosic, A; Studeny, P; Sugaya, T; Sun, S; Sun, X; Sunbul, SA; Supandi, AR; Suzuki, K; Suzuki, Y; Szczepański, MJ; Takahashi, Y; Taniguchi, R; Tao, Y; Tesli, M; Thirión-Romero, I; Tong, D; Trucchi, E; Tsuchido, Y; Turchetti, C; Turkina, SV; Turner, AW; Uldbjerg, N; Vinale, F; Wakamatsu, M; Walton, MA; Wang, C; Wang, Q; Wang, W; Wang, Y; Wang, Z; Wehberg, S; Wei, ZL; Wen, B; Whiteside, TL; Whittingham, MS; Widodo, ADW; Widłak, P; Wright, AI; Wu, H; Wu, Y; Wu, YL; Xiang, LG; Xiao, G; Xie, B; Xie, L; Xin, H; Xiong, J; Xiong, X; Xu, C; Xu, S; Yagubskii, EB; Yakushev, IA; Yang, H; Yang, J; Yao, J; Yao, ZX; Ye, J; Yerneni, SS; Yirgu, A; Yoshida, N; Yoshida, T; Young, SD; Yu, DN; Yuksel, A; Zac, J; Zac, S; Zarifkar, AH; Zhai, Y; Zhang, F; Zhang, H; Zhang, JW; Zhang, L; Zhang, Q; Zhang, X; Zhang, Y; Zhao, D; Zhao, J; Zhao, M; Zheng, D; Zheng, J; Zhou, G; Zhou, H; Zhu, P; Zhu, T; Zhu, Y; Zimmerman, MA; Zou, X | 1 |
| Ölmez, S; Otlu, B; Sancak, B; Şener, B | 1 |
| Arslan, N; Esen, N; Özkarataş, MH; Özkütük, AA | 1 |
| Dai, Y; Dai, ZQ; Li, L; Shi, YL; Yu, JY | 1 |
| Aceña, LE; Coolen, JPM; Jansen, RS; Koenderink, JB; Ruesen, C; Schildkraut, JA; Te Brake, LHM; van den Heuvel, JJMW; van Ingen, J; Wertheim, HFL | 1 |
| Faksri, K; Oudomying, N; Payungporn, S; Petsong, S; Prommi, A; Rotcheewaphan, S; Suankratay, C; Sukmongkolchai, S; Suwanpimolkul, G; Usawakidwiree, W; Wongjarit, K | 1 |
| Akiyama, Y; Horai, T; Iwamoto, N; Kamada, K; Mitarai, S; Nagashima, M; Ohmagari, N; Osugi, A; Suzuki, T; Yamamoto, K; Yoshida, A | 1 |
| Calado Nogueira de Moura, V; Daley, CL; Hunkins, JJ; Khare, R; Nguyen, MH | 1 |
| Faksri, K; Hinwan, Y; Kaewprasert, O; Sirichoat, A | 1 |
14 review(s) available for amikacin and clarithromycin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Patients with chronic sputum positive tuberculosis-a therapeutic problem].
Topics: Amikacin; Amoxicillin; Antitubercular Agents; Chronic Disease; Clarithromycin; Clofazimine; Humans; Rifabutin; Sputum; Tuberculosis, Pulmonary | 1995 |
Otitis media and mastoiditis due to Mycobacterium fortuitum: case report, review of four cases, and a cautionary note.
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Cefoxitin; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Mastoiditis; Mycobacterium Infections; Nontuberculous Mycobacteria; Otitis Media; Trimethoprim, Sulfamethoxazole Drug Combination | 1996 |
[Manifestations, diagnosis and treatment of non-tuberculous mycobacterial infections in patients with HIV infection].
Topics: Activities of Daily Living; AIDS-Related Opportunistic Infections; Amikacin; Anemia; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Cause of Death; Chemoprevention; Clarithromycin; Cytokines; Drug Therapy, Combination; Ethambutol; Fever; Granulocyte Colony-Stimulating Factor; Health Status; Humans; Immunocompromised Host; Immunotherapy; Incidence; Interferon-gamma; Molecular Biology; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Rifabutin; Tuberculosis; Virulence; Weight Loss | 1997 |
Disseminated Mycobacterium abscessus infection manifesting as fever of unknown origin and intra-abdominal lymphadenitis: case report and literature review.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Clarithromycin; Diagnosis, Differential; Exanthema; Fever of Unknown Origin; Humans; Immunocompromised Host; Lymph Nodes; Lymphadenitis; Male; Mycobacterium; Mycobacterium Infections; Tomography, X-Ray Computed | 2001 |
Rapid diagnosis and treatment of mycobacterial keratitis after laser in situ keratomileusis.
Topics: Amikacin; Bacteriological Techniques; Ciprofloxacin; Clarithromycin; Corneal Ulcer; Diagnostic Techniques, Ophthalmological; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Humans; Indicators and Reagents; Keratomileusis, Laser In Situ; Middle Aged; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Myopia; Postoperative Complications; Staining and Labeling; Tobramycin | 2003 |
Mycobacterium abscessus: an emerging rapid-growing potential pathogen.
Topics: Administration, Oral; Amikacin; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Cystic Fibrosis; Drug Resistance, Bacterial; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Minocycline; Mycobacterium; Mycobacterium Infections; Respiratory Tract Infections; Skin; Soft Tissue Infections; Species Specificity; Surgical Wound Infection; Tigecycline; Tuberculosis, Cutaneous; Wounds and Injuries | 2006 |
Localized cutaneous infections in immunocompetent individuals due to rapidly growing mycobacteria.
Topics: Amikacin; Anti-Bacterial Agents; Clarithromycin; Combined Modality Therapy; Debridement; Diagnosis, Differential; Humans; Immunity, Innate; Mycobacterium chelonae; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Skin; Skin Diseases, Bacterial | 2014 |
Infections Caused by Rapidly Growing Mycobacteria spp in Children and Adolescents With Cancer.
Topics: Adolescent; Amikacin; Anti-Infective Agents; Catheter-Related Infections; Child; Child, Preschool; Clarithromycin; Debridement; Female; Humans; Immunocompromised Host; Infant; Lung Diseases; Male; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium Infections; Neoplasms; Retrospective Studies | 2015 |
Delayed onset Mycobacterium intracellulare keratitis after laser in situ keratomileusis: A case report and literature review.
Topics: Administration, Topical; Adult; Amikacin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Eye Infections, Bacterial; Fluoroquinolones; Follow-Up Studies; Humans; Keratitis; Keratomileusis, Laser In Situ; Male; Moxifloxacin; Mycobacterium avium Complex; Severity of Illness Index; Treatment Outcome | 2017 |
Bilateral Non-tuberculous Mycobacterial Keratitis After Small Incision Lenticule Extraction.
Topics: Administration, Ophthalmic; Administration, Oral; Amikacin; Anti-Bacterial Agents; Clarithromycin; Corneal Surgery, Laser; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Fluoroquinolones; Humans; Imipenem; Microsurgery; Moxifloxacin; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Myopia; Refraction, Ocular; Surgical Flaps; Tomography, Optical Coherence; Visual Acuity; Young Adult | 2018 |
Topics: Aged; Amikacin; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Databases, Factual; Female; Humans; Imipenem; Lung Diseases; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous | 2019 |
Pulmonary Mycobacterium abscessus Infection in an 11-Year-Old Child, Successfully Treated with Inhaled/Parenteral Amikacin: A Case Report and Review of Literature.
Topics: Amikacin; Anti-Bacterial Agents; Child; Clarithromycin; Humans; Male; Microbial Sensitivity Tests; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous | 2021 |
Impact of dexamethasone and tocilizumab on hematological parameters in COVID-19 patients with chronic disease.
Topics: Acetaminophen; Acetylcarnitine; Acetylcholinesterase; Acids; Acinetobacter baumannii; Acinetobacter Infections; Adaptation, Psychological; Adolescent; Adsorption; Adult; Aged; Alcohol Drinking; Alzheimer Disease; Amikacin; Ammonia; Anaerobiosis; Animals; Anorexia; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Anxiety; Aptamers, Nucleotide; Asthenia; Attention Deficit Disorder with Hyperactivity; Bacterial Proteins; Beryllium; beta-Lactamases; Biofuels; Biomass; Biosensing Techniques; Bismuth; Blister; Body Mass Index; Body Surface Area; Boronic Acids; Brain; Breast Neoplasms; Butyrylcholinesterase; Cannabis; Carbapenems; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Carboxylic Acids; Carcinoma, Hepatocellular; Cardiovascular Diseases; Carnitine; Case-Control Studies; Catalysis; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Child; China; Cholinesterase Inhibitors; Clarithromycin; Clostridioides; Clostridioides difficile; Clostridium Infections; Cohort Studies; Colistin; Colitis; Colon; Coloring Agents; Coronary Artery Bypass; Creatinine; Crystalloid Solutions; Cytokines; Depression; Dextran Sulfate; Dextrans; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Diarrhea; Dietary Supplements; Diphenhydramine; Disease Models, Animal; Disease Outbreaks; Double-Blind Method; Doxorubicin; Drosophila; Drug Tapering; Dysbiosis; Electrons; Escherichia coli; Extracellular Vesicles; Fatigue; Female; Fermentation; gamma-Cyclodextrins; Gastrointestinal Microbiome; Glucose; Graft Survival; Graft vs Host Disease; Head and Neck Neoplasms; Heart Arrest, Induced; Hematopoietic Stem Cell Transplantation; High-Intensity Interval Training; Hippocampus; Humans; Hydrogen-Ion Concentration; Hypertension; Incidence; Interferon-gamma; Italy; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Lactoferrin; Larva; Length of Stay; Lignin; Liver; Liver Neoplasms; Liver Transplantation; Living Donors; Low Back Pain; Lung; Lung Volume Measurements; Macrophages; Male; Melphalan; Men; Mendelian Randomization Analysis; Meropenem; Methane; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mitochondrial Proteins; Molecular Docking Simulation; Molecular Structure; Mothers; Motivation; Mycoplasma; Mycoplasma hominis; Mycoplasma Infections; NAD; Nanocomposites; Nanoparticles; Nanotubes, Carbon; Naproxen; Neovascularization, Pathologic; Neurons; Nitrates; Nucleolin; Opuntia; Paratyphoid Fever; Phenotype; Phosphatidylinositol 3-Kinases; Phytochemicals; Plant Extracts; Pregnancy; Prevalence; Prospective Studies; Proto-Oncogene Proteins c-akt; Pulmonary Disease, Chronic Obstructive; Rats; Rats, Wistar; Resveratrol; Retrospective Studies; Rifampin; Risk Factors; RNA, Messenger; Selenium; Sleep; Social Behavior; Soil; Soil Pollutants; Squamous Cell Carcinoma of Head and Neck; Staphylococcus aureus; Structure-Activity Relationship; Suicidal Ideation; Suicide; Superoxide Dismutase-1; Surveys and Questionnaires; Swimming; Syndrome; Tannins; Temperature; Transforming Growth Factor beta; Transplantation Conditioning; Treatment Outcome; Triple Negative Breast Neoplasms; Troponin T; Tumor Microenvironment; United Kingdom; Ureaplasma; Ureaplasma urealyticum; Urinary Tract Infections; Viscum; Waste Disposal Facilities; Wastewater; Water; Water Pollutants, Chemical; Wolfiporia; Young Adult | 2022 |
1 trial(s) available for amikacin and clarithromycin
| Article | Year |
|---|---|
Impact of dexamethasone and tocilizumab on hematological parameters in COVID-19 patients with chronic disease.
Topics: Acetaminophen; Acetylcarnitine; Acetylcholinesterase; Acids; Acinetobacter baumannii; Acinetobacter Infections; Adaptation, Psychological; Adolescent; Adsorption; Adult; Aged; Alcohol Drinking; Alzheimer Disease; Amikacin; Ammonia; Anaerobiosis; Animals; Anorexia; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Anxiety; Aptamers, Nucleotide; Asthenia; Attention Deficit Disorder with Hyperactivity; Bacterial Proteins; Beryllium; beta-Lactamases; Biofuels; Biomass; Biosensing Techniques; Bismuth; Blister; Body Mass Index; Body Surface Area; Boronic Acids; Brain; Breast Neoplasms; Butyrylcholinesterase; Cannabis; Carbapenems; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Carboxylic Acids; Carcinoma, Hepatocellular; Cardiovascular Diseases; Carnitine; Case-Control Studies; Catalysis; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Child; China; Cholinesterase Inhibitors; Clarithromycin; Clostridioides; Clostridioides difficile; Clostridium Infections; Cohort Studies; Colistin; Colitis; Colon; Coloring Agents; Coronary Artery Bypass; Creatinine; Crystalloid Solutions; Cytokines; Depression; Dextran Sulfate; Dextrans; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Diarrhea; Dietary Supplements; Diphenhydramine; Disease Models, Animal; Disease Outbreaks; Double-Blind Method; Doxorubicin; Drosophila; Drug Tapering; Dysbiosis; Electrons; Escherichia coli; Extracellular Vesicles; Fatigue; Female; Fermentation; gamma-Cyclodextrins; Gastrointestinal Microbiome; Glucose; Graft Survival; Graft vs Host Disease; Head and Neck Neoplasms; Heart Arrest, Induced; Hematopoietic Stem Cell Transplantation; High-Intensity Interval Training; Hippocampus; Humans; Hydrogen-Ion Concentration; Hypertension; Incidence; Interferon-gamma; Italy; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Lactoferrin; Larva; Length of Stay; Lignin; Liver; Liver Neoplasms; Liver Transplantation; Living Donors; Low Back Pain; Lung; Lung Volume Measurements; Macrophages; Male; Melphalan; Men; Mendelian Randomization Analysis; Meropenem; Methane; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mitochondrial Proteins; Molecular Docking Simulation; Molecular Structure; Mothers; Motivation; Mycoplasma; Mycoplasma hominis; Mycoplasma Infections; NAD; Nanocomposites; Nanoparticles; Nanotubes, Carbon; Naproxen; Neovascularization, Pathologic; Neurons; Nitrates; Nucleolin; Opuntia; Paratyphoid Fever; Phenotype; Phosphatidylinositol 3-Kinases; Phytochemicals; Plant Extracts; Pregnancy; Prevalence; Prospective Studies; Proto-Oncogene Proteins c-akt; Pulmonary Disease, Chronic Obstructive; Rats; Rats, Wistar; Resveratrol; Retrospective Studies; Rifampin; Risk Factors; RNA, Messenger; Selenium; Sleep; Social Behavior; Soil; Soil Pollutants; Squamous Cell Carcinoma of Head and Neck; Staphylococcus aureus; Structure-Activity Relationship; Suicidal Ideation; Suicide; Superoxide Dismutase-1; Surveys and Questionnaires; Swimming; Syndrome; Tannins; Temperature; Transforming Growth Factor beta; Transplantation Conditioning; Treatment Outcome; Triple Negative Breast Neoplasms; Troponin T; Tumor Microenvironment; United Kingdom; Ureaplasma; Ureaplasma urealyticum; Urinary Tract Infections; Viscum; Waste Disposal Facilities; Wastewater; Water; Water Pollutants, Chemical; Wolfiporia; Young Adult | 2022 |
154 other study(ies) available for amikacin and clarithromycin
| Article | Year |
|---|---|
Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Antitubercular Agents; DNA, Bacterial; Drug Evaluation, Preclinical; Mycobacterium tuberculosis; Oxygen | 2007 |
Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; Canada; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Population Surveillance | 2008 |
Differential antibiotic susceptibility of Mycobacterium abscessus variants in biofilms and macrophages compared to that of planktonic bacteria.
Topics: Amikacin; Anti-Bacterial Agents; Biofilms; Cells, Cultured; Clarithromycin; Colony Count, Microbial; Host-Pathogen Interactions; Humans; Macrophages; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Plankton | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
In vitro activities of tigecycline and 10 other antimicrobials against nonpigmented rapidly growing mycobacteria.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Minocycline; Mycobacterium; Mycobacterium Infections; Pigmentation; Species Specificity; Tigecycline | 2008 |
Susceptibility of Mycobacterium bovis BCG vaccine strains to antituberculous antibiotics.
Topics: Antitubercular Agents; BCG Vaccine; Microbial Sensitivity Tests; Mycobacterium bovis | 2009 |
ATP synthase inhibition of Mycobacterium avium is not bactericidal.
Topics: Animals; Antitubercular Agents; Diarylquinolines; Enzyme Inhibitors; Female; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mycobacterium avium; Quinolines | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Prediction of Antibiotic Interactions Using Descriptors Derived from Molecular Structure.
Topics: Anti-Bacterial Agents; Drug Interactions; Molecular Structure | 2017 |
Activity of clarithromycin against Mycobacterium avium complex infection in beige mice.
Topics: Amikacin; Animals; Anti-Infective Agents; Antitubercular Agents; Clarithromycin; Clofazimine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ethambutol; Female; Fluoroquinolones; Humans; Mice; Mice, Inbred C57BL; Mycobacterium avium; Mycobacterium avium Complex; Quinolones; Rifabutin; Rifampin; Rifamycins; Time Factors; Tuberculosis | 1992 |
TLC G-65 in combination with other agents in the therapy of Mycobacterium avium infection in beige mice.
Topics: Amikacin; Animals; Antitubercular Agents; Clarithromycin; Clofazimine; Culture Media; Drug Therapy, Combination; Erythromycin; Ethambutol; Gentamicins; Liposomes; Mice; Mice, Inbred C57BL; Mycobacterium avium; Rifampin; Tuberculosis | 1992 |
Clarithromycin-ciprofloxacin-amikacin for therapy of Mycobacterium avium-Mycobacterium intracellulare bacteremia in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amikacin; Bacteremia; Cause of Death; Ciprofloxacin; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Erythromycin; Female; Humans; Male; Mycobacterium avium-intracellulare Infection; Pilot Projects | 1992 |
In vitro activity of clarithromycin alone or in combination with other antimicrobial agents against Mycobacterium avium-intracellulare. Complex strains isolated from AIDS patients.
Topics: Acquired Immunodeficiency Syndrome; Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Clofazimine; Drug Synergism; Drug Therapy, Combination; Erythromycin; Humans; Microbial Sensitivity Tests; Mycobacterium avium Complex; Radiometry | 1991 |
Atypical Mycobacterium and breast surgery.
Topics: Adult; Amikacin; Clarithromycin; Female; Humans; Imipenem; Mammaplasty; Mycobacterium Infections, Nontuberculous; Surgical Wound Infection | 1995 |
Selection of clarithromycin-resistant Mycobacterium avium complex during combined therapy using the beige mouse model.
Topics: Amikacin; Animals; Clarithromycin; Drug Resistance, Microbial; Ethambutol; Female; Humans; Lung; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mutation; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifabutin; Spleen | 1995 |
In vitro and ex vivo activities of antimicrobial agents used in combination with clarithromycin, with or without amikacin, against Mycobacterium avium.
Topics: Amikacin; Clarithromycin; Drug Therapy, Combination; Humans; In Vitro Techniques; Macrophages; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection | 1995 |
[Evaluation of the extra- and intracellular activity of clarithromycin against Mycobacterium chelonae].
Topics: Amikacin; Clarithromycin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ethambutol; In Vitro Techniques; Mycobacterium chelonae; Radiometry; Rifabutin | 1994 |
Comparison of topical antibiotics for treating Mycobacterium fortuitum keratitis in an animal model.
Topics: Administration, Topical; Amikacin; Animals; Ciprofloxacin; Clarithromycin; Colony Count, Microbial; Corneal Stroma; Disease Models, Animal; Drug Therapy, Combination; Eye Infections, Bacterial; Keratitis; Male; Mycobacterium Infections, Nontuberculous; Ophthalmic Solutions; Rabbits; Vancomycin | 1993 |
Susceptibility of Mycobacterium malmoense to antibacterial drugs and drug combinations.
Topics: Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Ethambutol; Humans; Microbial Sensitivity Tests; Mycobacterium; Rifabutin; Rifampin; Rifamycins | 1993 |
The management of mycobacterial infections in HIV seropositive individuals. Jefferiss Wing Therapeutics and Protocols Group.
Topics: Adrenal Cortex Hormones; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Antitubercular Agents; Ciprofloxacin; Clarithromycin; Clofazimine; Drug Therapy, Combination; Ethambutol; HIV Infections; Humans; Isoniazid; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections; Nontuberculous Mycobacteria; Practice Guidelines as Topic; Pyrazinamide; Pyridoxine; Radiography; Rifabutin; Rifampin; Tuberculosis, Meningeal; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1996 |
Comparative activities of amikacin against Mycobacterium avium complex in nude and beige mice.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Clarithromycin; Female; Mice; Mice, Nude; Mycobacterium avium; Predictive Value of Tests; Species Specificity; Tuberculosis | 1997 |
Activity of rifabutin, clarithromycin, ethambutol, sparfloxacin and amikacin, alone and in combination, against Mycobacterium avium complex in human macrophages.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Antitubercular Agents; Clarithromycin; Drug Therapy, Combination; Ethambutol; Fluoroquinolones; Humans; Macrophages; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Quinolones; Rifabutin | 1996 |
Evaluation of the post-antibiotic effect of six anti-mycobacterial agents against Mycobacterium avium by the Bactec radiometric method.
Topics: Amikacin; Antitubercular Agents; Cell Division; Ciprofloxacin; Clarithromycin; Drug Therapy, Combination; Ethambutol; Isoniazid; Microbial Sensitivity Tests; Mycobacterium avium; Radiometry; Rifampin | 1997 |
Rapid drug susceptibility of Mycobacterium avium complex using a fluorescence quenching method.
Topics: Acquired Immunodeficiency Syndrome; Agar; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Ciprofloxacin; Clarithromycin; Fluoroimmunoassay; Humans; Microbial Sensitivity Tests; Mycobacterium avium; Nucleic Acid Hybridization; Rifabutin | 1997 |
Mycobacterium chelonae keratitis after excimer laser photorefractive keratectomy.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Cornea; Corneal Ulcer; Eye Infections, Bacterial; Follow-Up Studies; Humans; Lasers, Excimer; Male; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Myopia; Photorefractive Keratectomy; Postoperative Complications; Visual Acuity; Wound Healing | 1997 |
Activities of isoniazid alone and in combination with other drugs against Mycobacterium avium infection in beige mice.
Topics: Amikacin; Animals; Clarithromycin; Drug Therapy, Combination; Humans; Isoniazid; Lung; Mice; Mycobacterium avium; Spleen; Tuberculosis | 1998 |
Paradoxical local response to therapy for Mycobacterium avium complex infection in four patients with AIDS.
Topics: Adult; AIDS-Related Opportunistic Infections; Amikacin; Anti-Bacterial Agents; Clarithromycin; Hepatomegaly; Humans; Lymph Nodes; Male; Mycobacterium avium-intracellulare Infection | 1998 |
Atypical cervico-facial mycobacterial infections in childhood.
Topics: Algorithms; Amikacin; Anti-Bacterial Agents; Child; Child, Preschool; Ciprofloxacin; Clarithromycin; Diagnosis, Differential; Drug Combinations; Face; Female; Humans; Lymph Node Excision; Lymphadenitis; Mycobacterium Infections, Nontuberculous; Neck; Nontuberculous Mycobacteria; Skin Tests; Trimethoprim, Sulfamethoxazole Drug Combination | 1998 |
Postantibiotic effect of amikacin, rifampin, sparfloxacin, clofazimine and clarithromycin against Mycobacterium avium.
Topics: Amikacin; Anti-Bacterial Agents; Bacteriological Techniques; Clarithromycin; Clofazimine; Colony Count, Microbial; Fluoroquinolones; Humans; Mycobacterium avium Complex; Quinolones; Rifampin; Serum Bactericidal Test | 1997 |
Pulsed-exposure and postantibiotic leukocyte enhancement effects of amikacin, clarithromycin, clofazimine, and rifampin against intracellular Mycobacterium avium.
Topics: Amikacin; Anti-Bacterial Agents; Clarithromycin; Clofazimine; Humans; Leukocytes; Macrophages; Mycobacterium avium; Phagocytosis; Rifampin | 1998 |
Comparison of the E test and a proportion dilution method for susceptibility testing of Mycobacterium tuberculosis.
Topics: Amikacin; Antitubercular Agents; Ciprofloxacin; Clarithromycin; Fleroxacin; Fusidic Acid; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin | 1995 |
Treatment of disseminated Mycobacterium genavense infection in a murine model with ciprofloxacin, amikacin, ethambutol, clarithromycin and rifabutin.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Mice; Mice, Inbred C57BL; Mycobacterium; Mycobacterium Infections; Rifabutin; Spleen | 1998 |
Postantibiotic effects of rifampin, amikacin, clarithromycin and ethambutol used alone or in various two-, three- and four-drug combinations against Mycobacterium avium.
Topics: AIDS-Related Opportunistic Infections; Amikacin; Anti-Bacterial Agents; Antitubercular Agents; Clarithromycin; Colony Count, Microbial; Drug Therapy, Combination; Ethambutol; Humans; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Radiometry; Rifampin | 1999 |
Multisite reproducibility of results obtained by the broth microdilution method for susceptibility testing of Mycobacterium abscessus, Mycobacterium chelonae, and Mycobacterium fortuitum.
Topics: Amikacin; Anti-Bacterial Agents; Cefoxitin; Ciprofloxacin; Clarithromycin; Culture Media; Doxycycline; Humans; Imipenem; Microbial Sensitivity Tests; Mycobacterium chelonae; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Sulfamethoxazole; Tobramycin | 1999 |
Use of a low nutrient culture medium for the identification of bacteria causing severe ocular infection.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Ciprofloxacin; Clarithromycin; Culture Media; Endophthalmitis; Eye Infections, Bacterial; Female; Humans; Keratitis; Male; Middle Aged; Propionibacterium acnes; Pseudomonas aeruginosa; Staphylococcus aureus; Vancomycin | 1999 |
Activities of eighteen antimicrobial regimens against Mycobacterium avium infection in beige mice.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Male; Mice; Mycobacterium avium; Tuberculosis | 1999 |
Eradication of mycobacterium abscessus in a chronically infected patient with cystic fibrosis.
Topics: Administration, Inhalation; Administration, Oral; Adult; Amikacin; Anti-Bacterial Agents; Chronic Disease; Clarithromycin; Cystic Fibrosis; Drug Therapy, Combination; Female; Humans; Lung Abscess; Mycobacterium; Mycobacterium Infections; Recurrence | 2000 |
[Pulmonary Nocardia otitidiscaviarum infection in an immunocompetent host].
Topics: Aged; Amikacin; Clarithromycin; Community-Acquired Infections; Drug Therapy, Combination; Humans; Immunocompromised Host; Male; Nocardia; Nocardia Infections; Pneumonia; Treatment Outcome | 2000 |
Molecular diagnosis of a Mycobacterium chelonae infection.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Clarithromycin; DNA, Bacterial; Female; Humans; Imipenem; Lymph Nodes; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Polymerase Chain Reaction | 2001 |
MAC management.
Topics: Acquired Immunodeficiency Syndrome; Amikacin; Antitubercular Agents; Ciprofloxacin; Clarithromycin; Clofazimine; Drug Interactions; Drug Therapy, Combination; Ethambutol; Humans; Mycobacterium avium-intracellulare Infection; Rifabutin; Rifampin; Tuberculin Test; Zidovudine | 1996 |
Madura foot: treatment of Nocardia nova infection with antibiotics alone.
Topics: Administration, Oral; Adult; Amikacin; Clarithromycin; Doxycycline; Drug Therapy, Combination; Erythromycin; Female; Follow-Up Studies; Foot Bones; Foot Dermatoses; Humans; Infusions, Intravenous; Nocardia; Nocardia Infections; Obesity, Morbid; Severity of Illness Index; Treatment Outcome | 2001 |
Failure of treatment for chronic Mycobacterium abscessus meningitis despite adequate clarithromycin levels in cerebrospinal fluid.
Topics: Amikacin; Anti-Bacterial Agents; Clarithromycin; Female; Humans; Meningitis, Bacterial; Microbial Sensitivity Tests; Middle Aged; Mycobacterium; Mycobacterium Infections; Spinal Puncture; Treatment Failure | 2001 |
Mycobacterium interface keratitis after laser in situ keratomileusis.
Topics: Adult; Amikacin; Clarithromycin; Cornea; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Humans; Keratitis; Keratomileusis, Laser In Situ; Male; Middle Aged; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Time Factors | 2001 |
[Soft-tissue abscess caused by Rhodococcus equi in a patient on hemodialysis].
Topics: Abscess; Actinomycetales Infections; Adrenal Cortex Hormones; Aged; Amikacin; Anti-Glomerular Basement Membrane Disease; Ciprofloxacin; Clarithromycin; Cyclophosphamide; Disease Susceptibility; Drug Therapy, Combination; Female; Humans; Imipenem; Immunocompromised Host; Immunosuppressive Agents; Kidney Failure, Chronic; Opportunistic Infections; Pneumonia, Bacterial; Renal Dialysis; Rhodococcus equi; Thigh | 2001 |
Bilateral Mycobacterium abscessus keratitis after laser in situ keratomileusis.
Topics: Adult; Amikacin; Clarithromycin; Corneal Stroma; Drug Therapy, Combination; Eye Infections, Bacterial; Humans; Keratitis; Keratomileusis, Laser In Situ; Male; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Myopia; Surgical Flaps; Visual Acuity | 2002 |
Bactericidal activity of rifampin-amikacin against Mycobacterium ulcerans in mice.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Clarithromycin; Colony Count, Microbial; Disease Models, Animal; Drug Therapy, Combination; Female; Fluoroquinolones; Foot; Mice; Mice, Inbred BALB C; Mycobacterium Infections, Nontuberculous; Mycobacterium ulcerans; Rifampin; Skin Ulcer | 2002 |
In vitro sensitivity of Mycobacterium xenopi to five antibiotics.
Topics: Amikacin; Anti-Bacterial Agents; Clarithromycin; Ethambutol; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Mycobacterium xenopi; Ofloxacin; Rifampin | 2002 |
A comparison between disk diffusion and microdilution for susceptibility testing of Mycobacterium fortuitum complex.
Topics: Amikacin; Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Clarithromycin; Colony Count, Microbial; Erythromycin; Microbial Sensitivity Tests; Mycobacterium fortuitum; Ofloxacin; Tetracycline | 2002 |
Early chemotherapy for non-tuberculous mycobacterial infections in patients with cystic fibrosis.
Topics: Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Antitubercular Agents; Child; Clarithromycin; Cohort Studies; Cystic Fibrosis; Ethambutol; Female; Humans; Male; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Retrospective Studies; Rifampin; Streptomycin | 2003 |
[A case of lung infection due to Mycobacterium abscessus].
Topics: Amikacin; Cilastatin; Cilastatin, Imipenem Drug Combination; Clarithromycin; Drug Combinations; Drug Therapy, Combination; Female; Humans; Imipenem; Middle Aged; Minocycline; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Radiography; Sputum; Tuberculosis, Pulmonary | 2003 |
In vitro susceptibility of nocardia species to cethromycin, clarithromycin and amikacin.
Topics: Amikacin; Clarithromycin; Drug Resistance, Bacterial; Erythromycin; Humans; Ketolides; Microbial Sensitivity Tests; Nocardia; Sampling Studies; Sensitivity and Specificity | 2004 |
[Treatment and a follow-up study on wound infection by Mycobacterium chelonae: report of 168 cases].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Child; Child, Preschool; Clarithromycin; Combined Modality Therapy; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Infant; Male; Middle Aged; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Surgical Wound Infection | 2004 |
Comparative efficacy of topical gatifloxacin with ciprofloxacin, amikacin, and clarithromycin in the treatment of experimental Mycobacterium chelonae keratitis.
Topics: Administration, Topical; Amikacin; Animals; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Cornea; Corneal Ulcer; Disease Models, Animal; Drug Therapy, Combination; Eye Infections, Bacterial; Fluoroquinolones; Gatifloxacin; Male; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Ophthalmic Solutions; Rabbits | 2004 |
[A case of bronchial ulcer due to infection by Mycobacterium abscessus].
Topics: Aged; Amikacin; Anti-Bacterial Agents; Bronchial Diseases; Bronchitis; Cefoxitin; Clarithromycin; Drug Therapy, Combination; Humans; Male; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Tracheitis; Ulcer | 2004 |
Mycobacterium chelonae wound ulcer after clear-cornea cataract surgery.
Topics: Aged; Aged, 80 and over; Amikacin; Cataract Extraction; Clarithromycin; Cornea; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Humans; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Surgical Wound Infection | 2004 |
Clarithromycin co-administered with amikacin attenuates systemic inflammation in experimental sepsis with Escherichia coli.
Topics: Acute Disease; Amikacin; Animals; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Female; Humans; Inflammation; Lipopolysaccharides; Malondialdehyde; Pyelonephritis; Rabbits; Sepsis; Treatment Outcome; Tumor Necrosis Factor-alpha | 2005 |
Clarithromycin: immunomodulatory therapy of experimental sepsis and acute pyelonephritis by Escherichia coli.
Topics: Acute Disease; Amikacin; Animals; Anti-Bacterial Agents; Caspase 3; Caspases; Clarithromycin; Colony Count, Microbial; Escherichia coli; Escherichia coli Infections; Immunologic Factors; Male; Malondialdehyde; Pulmonary Edema; Pyelonephritis; Rabbits; Sepsis; Tumor Necrosis Factor-alpha | 2005 |
Mycobacterium simiae: a previously undescribed pathogen in peritoneal dialysis peritonitis.
Topics: Adult; AIDS-Related Opportunistic Infections; Amikacin; Amoxicillin; Antiretroviral Therapy, Highly Active; Candidiasis, Oral; Ciprofloxacin; Clarithromycin; Drug Therapy, Combination; Equipment Contamination; Gentamicins; Humans; Immunocompromised Host; Kidney Failure, Chronic; Male; Mycobacterium; Mycobacterium Infections; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Pneumonia, Pneumocystis; Renal Dialysis; Rifabutin; Vancomycin | 2005 |
Antimycobacterial agents differ with respect to their bacteriostatic versus bactericidal activities in relation to time of exposure, mycobacterial growth phase, and their use in combination.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Colony Count, Microbial; Ethambutol; Humans; Microbial Sensitivity Tests; Mycobacterium avium Complex; Quinolones; Rifampin | 2005 |
Osteomyelitis of the mandible due to Mycobacterium abscessus: a case report.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Female; Humans; Mandibular Diseases; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Osteomyelitis; Rifampin; Root Canal Therapy | 2005 |
A successfully treated case of mycetoma due to Nocardia veterana.
Topics: Adult; Amikacin; Cilastatin; Clarithromycin; Drug Therapy, Combination; Female; Humans; Imipenem; Minocycline; Mycetoma; Nocardia; Occupational Diseases; Treatment Outcome | 2005 |
Mycobacterium kansasii: antibiotic susceptibility and PCR-restriction analysis of clinical isolates.
Topics: Amikacin; Anti-Bacterial Agents; Brazil; Ciprofloxacin; Clarithromycin; Clofazimine; Cycloserine; DNA Fingerprinting; DNA, Bacterial; Doxycycline; Drug Resistance, Bacterial; Ethambutol; Ethionamide; Genotype; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Rifabutin; Rifampin; Streptomycin | 2005 |
Iatrogenic Mycobacterium abscessus infection associated with acupuncture: clinical manifestations and its treatment.
Topics: Acupuncture Therapy; Adult; Amikacin; Anti-Bacterial Agents; Clarithromycin; Female; Humans; Iatrogenic Disease; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Skin; Skin Diseases, Bacterial; Time Factors; Treatment Outcome | 2005 |
Clarithromycin is an effective immunomodulator when administered late in experimental pyelonephritis by multidrug-resistant Pseudomonas aeruginosa.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Clarithromycin; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Immunologic Factors; Kidney; Lipopolysaccharides; Liver; Lung; Male; Malondialdehyde; Monocytes; Pseudomonas aeruginosa; Pseudomonas Infections; Pyelonephritis; Rabbits; Spleen; Tumor Necrosis Factor-alpha | 2006 |
Concomitant late soft tissue infections by Cladophialophora bantiana and Mycobacterium abscessus following tsunami injuries.
Topics: Amikacin; Anti-Bacterial Agents; Antifungal Agents; Ascomycota; Clarithromycin; Dermatomycoses; Disasters; Female; Humans; Male; Middle Aged; Mycobacterium; Mycobacterium Infections; Pyrimidines; Soft Tissue Infections; Soft Tissue Injuries; Triazoles; Voriconazole; Wounds and Injuries | 2006 |
Recalcitrant post-LASIK Mycobacterium chelonae keratitis eradicated after the use of fourth-generation fluoroquinolone.
Topics: Adult; Amikacin; Amputation, Surgical; Anti-Bacterial Agents; Clarithromycin; Corneal Stroma; Debridement; Drug Therapy, Combination; Eye Infections, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; Keratitis; Keratomileusis, Laser In Situ; Male; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Ophthalmic Solutions; Postoperative Complications; Surgical Flaps | 2006 |
Mycobacterium abscessus endophthalmitis: treatment dilemma and review of the literature.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Clarithromycin; Combined Modality Therapy; Device Removal; Endophthalmitis; Eye Infections, Bacterial; Female; Humans; Lens Implantation, Intraocular; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Phacoemulsification; Postoperative Complications; Vitrectomy; Vitreous Body | 2006 |
Disseminated nontuberculous mycobacterial infections in sickle cell anemia patients.
Topics: Acetamides; Adolescent; Amikacin; Anemia, Sickle Cell; Anti-Bacterial Agents; Cefoxitin; Ciprofloxacin; Clarithromycin; Doxycycline; Drug Therapy, Combination; Female; Humans; Hydroxyurea; Linezolid; Microbial Sensitivity Tests; Mycobacterium fortuitum; Mycobacterium Infections; Oxazolidinones; Treatment Outcome | 2006 |
The expanding spectrum of Mycobacterium avium complex-associated pulmonary disease.
Topics: Adult; Amikacin; Biopsy; Clarithromycin; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Female; Granuloma; Humans; Lung; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Necrosis; Pneumonia, Bacterial; Prednisone; Rifampin; Sputum; Tomography, X-Ray Computed | 2006 |
[A case of Mycobacterium abscessus pulmonary infection; effectiveness of clarithromycin, amikacin and imipenem/cilastatin].
Topics: Adult; Amikacin; Anti-Bacterial Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Clarithromycin; Drug Combinations; Drug Therapy, Combination; Female; Humans; Imipenem; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Radiography, Thoracic; Tuberculosis, Pulmonary | 2006 |
Targeted drug delivery to enhance efficacy and shorten treatment duration in disseminated Mycobacterium avium infection in mice.
Topics: Amikacin; Animals; Antitubercular Agents; Clarithromycin; Drug Administration Schedule; Drug Delivery Systems; Ethambutol; Female; Liposomes; Mice; Mice, Inbred C57BL; Mycobacterium avium; Rifampin; Specific Pathogen-Free Organisms; Tuberculosis | 2007 |
Fourth-generation fluoroquinolone-resistant mycobacterial keratitis after laser in situ keratomileusis.
Topics: Adult; Amikacin; Anti-Infective Agents; Aza Compounds; Clarithromycin; Corneal Ulcer; Doxycycline; Drug Resistance, Bacterial; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Fluoroquinolones; Gatifloxacin; Humans; Keratomileusis, Laser In Situ; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Quinolines | 2007 |
[Cutaneous non-tuberculous mycobacterial infection following cord blood stem cell transplantation].
Topics: Amikacin; Anti-Bacterial Agents; Child, Preschool; Clarithromycin; Cord Blood Stem Cell Transplantation; Diagnosis, Differential; Female; Humans; Immunocompromised Host; Lymphohistiocytosis, Hemophagocytic; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Skin Diseases, Bacterial; Treatment Outcome | 2008 |
Antibiotic treatment of Mycobacterium abscessus lung disease: a retrospective analysis of 65 patients.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Cefoxitin; Chemical and Drug Induced Liver Injury; Ciprofloxacin; Clarithromycin; Doxycycline; Drug Therapy, Combination; Female; Humans; Liver; Lung; Lung Diseases; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Neutropenia; Nontuberculous Mycobacteria; Retrospective Studies; Sputum; Thrombocytopenia; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
[Three cases of panniculitis due to Mycobacterium abscessus after mesotherapy].
Topics: Abscess; Adult; Amikacin; Anti-Bacterial Agents; Clarithromycin; Combined Modality Therapy; Cosmetic Techniques; Disease Outbreaks; Drainage; Female; Humans; Injections, Intradermal; Materia Medica; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Opportunistic Infections; Panniculitis; Skin Ulcer; Spain; Tuberculoma; Wound Infection | 2010 |
Bilateral parotitis caused by Mycobacterium chelonae in an immunocompetent child.
Topics: Amikacin; Anti-Bacterial Agents; Child, Preschool; Clarithromycin; Debridement; Drug Therapy, Combination; Humans; Male; Microbial Sensitivity Tests; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Parotid Gland; Parotitis | 2009 |
Aerosolized amikacin and oral clarithromycin to eradicate Mycobacterium abscessus in a patient with cystic fibrosis: an 8-year follow-up.
Topics: Administration, Oral; Adult; Amikacin; Anti-Bacterial Agents; Clarithromycin; Cystic Fibrosis; Drug Therapy, Combination; Female; Forced Expiratory Volume; Gram-Negative Bacterial Infections; Humans; Mycobacterium; Mycobacterium Infections; Nebulizers and Vaporizers; Pseudomonas aeruginosa; Pseudomonas Infections; Stenotrophomonas maltophilia | 2010 |
Clinical significance of differentiation of Mycobacterium massiliense from Mycobacterium abscessus.
Topics: Amikacin; Antibiotics, Antitubercular; Cefoxitin; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Retrospective Studies; Sputum; Treatment Outcome | 2011 |
Clarithromycin and amikacin vs. clarithromycin and moxifloxacin for the treatment of post-acupuncture cutaneous infections due to Mycobacterium abscessus: a prospective observational study.
Topics: Acupuncture Therapy; Amikacin; Anti-Bacterial Agents; Aza Compounds; Clarithromycin; Disease Outbreaks; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Korea; Male; Middle Aged; Moxifloxacin; Mycobacterium; Mycobacterium Infections; Prospective Studies; Quinolines; Skin Diseases, Bacterial; Time Factors; Treatment Outcome | 2011 |
Clinical outcome of Mycobacterium abscessus infection and antimicrobial susceptibility testing.
Topics: Amikacin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Humans; Lung Diseases; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Treatment Outcome | 2010 |
Importance of antibiotic penetration in the antimicrobial resistance of biofilm formed by non-pigmented rapidly growing mycobacteria against amikacin, ciprofloxacin and clarithromycin.
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Load; Biofilms; Ciprofloxacin; Clarithromycin; Drug Resistance, Multiple, Bacterial; In Vitro Techniques; Microbial Sensitivity Tests; Mycobacterium; Nontuberculous Mycobacteria; Species Specificity | 2011 |
Effect of the combination of clarithromycin and amikacin on Pseudomonas aeruginosa biofilm in an animal model of ureteral stent infection.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Biofilms; Clarithromycin; Coated Materials, Biocompatible; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Female; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Rats, Wistar; Stents; Ureteral Diseases | 2011 |
Facial cellulitis because of Aggregatibacter (Actinobacillus) actinomycetemcomitans and Capnocytophaga species in an immunocompetent patient.
Topics: Actinobacillus Infections; Administration, Oral; Adolescent; Aggregatibacter actinomycetemcomitans; Amikacin; Capnocytophaga; Cellulitis; Clarithromycin; Face; Female; Gram-Negative Bacterial Infections; Humans | 2011 |
[Pleuropneumonia due to Mycobacterium chelonae].
Topics: Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bronchiectasis; Clarithromycin; Drainage; Drug Therapy, Combination; Humans; Male; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Pleuropneumonia; Risk Factors; Treatment Outcome | 2011 |
Ocular infections caused by non-tuberculous mycobacteria: update on epidemiology and management.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Aza Compounds; Child; Child, Preschool; Clarithromycin; Combined Modality Therapy; Corneal Ulcer; Eye Infections, Bacterial; Female; Florida; Fluoroquinolones; Humans; Incidence; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Ophthalmologic Surgical Procedures; Quinolines; Retrospective Studies; Risk Factors; Surgical Wound Infection; Young Adult | 2012 |
Two-drug antimicrobial chemotherapy: a mathematical model and experiments with Mycobacterium marinum.
Topics: Amikacin; Anti-Infective Agents; Clarithromycin; Computer Simulation; Dose-Response Relationship, Drug; Drug Combinations; Drug Interactions; Drug Resistance, Multiple; Humans; Microbial Sensitivity Tests; Models, Biological; Models, Theoretical; Mycobacterium Infections, Nontuberculous; Mycobacterium marinum; Rifampin; Tuberculosis | 2012 |
Lung abscess due to non-tuberculous, non-Mycobacterium fortuitum in a neonate.
Topics: Amikacin; Anti-Bacterial Agents; Clarithromycin; Female; Humans; Infant, Newborn; Lung Abscess; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Radiography; Treatment Outcome | 2012 |
The pharmacokinetics and pharmacodynamics of pulmonary Mycobacterium avium complex disease treatment.
Topics: Adult; Aged; Amikacin; Antibiotics, Antitubercular; Area Under Curve; Clarithromycin; Cohort Studies; Colorado; Drug Interactions; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Pneumonia, Bacterial; Retrospective Studies; Rifabutin; Rifampin | 2012 |
Periprosthetic atypical mycobacterial infection in breast implants: a new kid on the block!
Topics: Acetamides; Adult; Amikacin; Anti-Bacterial Agents; Antitubercular Agents; Breast Implants; Clarithromycin; Female; Fluoroquinolones; Gatifloxacin; Humans; Linezolid; Mammaplasty; Mycobacterium chelonae; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Oxazolidinones; Reoperation | 2013 |
Synergistic activities of tigecycline with clarithromycin or amikacin against rapidly growing mycobacteria in Taiwan.
Topics: Amikacin; Anti-Bacterial Agents; Clarithromycin; Drug Synergism; Humans; Microbial Sensitivity Tests; Minocycline; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Taiwan; Tigecycline | 2013 |
Mycobacterium abscessus complex lung infection in a toddler with a tracheostomy.
Topics: Amikacin; Anti-Bacterial Agents; Bronchopulmonary Dysplasia; Child, Preschool; Clarithromycin; Female; Humans; Laryngostenosis; Minocycline; Mycobacterium Infections, Nontuberculous; Tigecycline; Tomography, X-Ray Computed; Tracheostomy; Tuberculosis, Pulmonary | 2014 |
Clinical isolates of Mycobacterium abscessus in Guangzhou area most possibly from the environmental infection showed variable susceptibility.
Topics: Amikacin; Anti-Bacterial Agents; Cefoxitin; China; Chromatography, Gas; Ciprofloxacin; Clarithromycin; Imipenem; Microbial Sensitivity Tests; Mycobacterium; Polymerase Chain Reaction; Random Amplified Polymorphic DNA Technique | 2013 |
[The treatment outcomes of 21 cases of rapidly growing mycobacteria related pulmonary disease].
Topics: Adult; Aged; Amikacin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Humans; Lung Diseases; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium Infections; Nontuberculous Mycobacteria; Retrospective Studies; Sputum; Treatment Outcome; Young Adult | 2013 |
Post-operative sinus formation due to Mycobacterium abscessus: a case report.
Topics: Adult; Amikacin; Antitubercular Agents; Cholecystectomy, Laparoscopic; Cholecystitis, Acute; Clarithromycin; Female; Humans; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Surgical Wound Infection; Treatment Outcome | 2013 |
[Drug sensitivity analysis of Mycobacterium chelonae and Mycobacterium abscessus and evaluation of Etest for susceptibility testing].
Topics: Acetamides; Amikacin; Anti-Bacterial Agents; Cefoxitin; Clarithromycin; Culture Media; Humans; Linezolid; Microbial Sensitivity Tests; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Oxazolidinones; Sensitivity and Specificity; Tobramycin | 2013 |
[Case report; Disseminated Mycobacterium abscessus infection with hemophagocytic syndrome during treatment of chronic lymphocytic leukemia].
Topics: Amikacin; Anemia, Hemolytic, Autoimmune; Anti-Bacterial Agents; Clarithromycin; Cyclophosphamide; Humans; Imipenem; Immunocompromised Host; Immunoglobulins, Intravenous; Immunosuppressive Agents; Leukemia, Lymphocytic, Chronic, B-Cell; Levofloxacin; Lymphohistiocytosis, Hemophagocytic; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Opportunistic Infections; Prednisolone; Treatment Outcome | 2014 |
[The analysis of species identification and susceptibility testing of Mycobacterium abscessus].
Topics: Amikacin; Anti-Bacterial Agents; Antibiotics, Antitubercular; Azithromycin; Cefoxitin; Clarithromycin; Humans; Nontuberculous Mycobacteria; RNA, Ribosomal, 16S | 2014 |
Significant difference in drug susceptibility distribution between Mycobacterium avium and Mycobacterium intracellulare.
Topics: Amikacin; Antitubercular Agents; Clarithromycin; Humans; Microbial Sensitivity Tests; Mycobacterium avium; Mycobacterium avium Complex | 2014 |
Nontuberculous mycobacterial ocular infections--comparing the clinical and microbiological characteristics between Mycobacterium abscessus and Mycobacterium massiliense.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Infective Agents; Child; Clarithromycin; Drug Resistance, Bacterial; Eye Infections, Bacterial; Humans; Microbial Sensitivity Tests; Middle Aged; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Young Adult | 2015 |
Use of Topical Besifloxacin in the Treatment of Mycobacterium chelonae Ocular Surface Infections.
Topics: Administration, Topical; Aged; Amikacin; Anti-Bacterial Agents; Azepines; Clarithromycin; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Fluoroquinolones; Humans; Middle Aged; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Ophthalmic Solutions; Retrospective Studies; Topoisomerase II Inhibitors; Visual Acuity | 2015 |
Mycobacterium fortuitum thoracic empyema: A case report and review of the literature.
Topics: Amikacin; Anti-Bacterial Agents; Chronic Disease; Cilastatin; Cilastatin, Imipenem Drug Combination; Clarithromycin; Drug Combinations; Drug Therapy, Combination; Empyema, Pleural; Humans; Hypercapnia; Imipenem; Male; Middle Aged; Mycobacterium fortuitum; Noninvasive Ventilation; Sulfamethoxazole | 2015 |
Time-kill kinetics of slowly growing mycobacteria common in pulmonary disease.
Topics: Amikacin; Anti-Bacterial Agents; Clarithromycin; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Microbial Sensitivity Tests; Mutation; Mutation Rate; Mycobacterium avium; Mycobacterium xenopi; Time Factors | 2015 |
Effect of Antibiotics and Antibiofilm Agents in the Ultrastructure and Development of Biofilms Developed by Nonpigmented Rapidly Growing Mycobacteria.
Topics: Acetylcysteine; Amikacin; Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Clarithromycin; Microbial Sensitivity Tests; Microscopy, Confocal; Mycobacterium; Polysorbates | 2016 |
Assessing primary and secondary resistance to clarithromycin and amikacin in infections due to Mycobacterium avium complex.
Topics: Amikacin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Microbial Sensitivity Tests; Mycobacterium avium Complex | 2015 |
[A CASE OF PULMONARY MYCOBACTERIUM ABSCESSUS INFECTION SUCCESSFULLY TREATED WITH SHORT-TERM CAM, AMK, AND IPM/cs FOLLOWED BY LONG-TERM ORAL CAM AND LVFX].
Topics: Administration, Oral; Aged; Amikacin; Anti-Bacterial Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Clarithromycin; Drug Combinations; Female; Humans; Imipenem; Levofloxacin; Lung Diseases; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria | 2015 |
Successful resumption of tocilizumab for rheumatoid arthritis after resection of a pulmonary Mycobacterium avium complex lesion: a case report.
Topics: Amikacin; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Clarithromycin; Ethambutol; Female; Humans; Immunocompromised Host; Lung; Middle Aged; Mycobacterium avium-intracellulare Infection; Pneumonectomy; Rifampin; Tomography, X-Ray Computed | 2015 |
Clofazimine Prevents the Regrowth of Mycobacterium abscessus and Mycobacterium avium Type Strains Exposed to Amikacin and Clarithromycin.
Topics: Amikacin; Anti-Bacterial Agents; Clarithromycin; Clofazimine; Drug Interactions; Drug Synergism; Drug Therapy, Combination; Microbial Sensitivity Tests; Monte Carlo Method; Mutation; Mycobacterium avium; Nontuberculous Mycobacteria | 2016 |
Tattoo-associated mycobacterial infections: an emerging public health issue.
Topics: Amikacin; Anti-Bacterial Agents; Australia; Cefoxitin; Clarithromycin; Drug Therapy, Combination; Humans; Male; Mycobacterium Infections; Public Health; Tattooing; Young Adult | 2015 |
Pulmonary Mycobacterium abscessus Infection in a Patient with Triple A Syndrome.
Topics: Adrenal Insufficiency; Amikacin; Anti-Bacterial Agents; Child; Clarithromycin; Esophageal Achalasia; Humans; Imipenem; Male; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Treatment Outcome | 2016 |
Mycobacterium chelonae Scleral Abscess After Intravitreal Ranibizumab Injection.
Topics: Abscess; Amikacin; Angiogenesis Inhibitors; Anti-Bacterial Agents; Clarithromycin; Diabetic Retinopathy; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Humans; Intravitreal Injections; Macular Edema; Middle Aged; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Ranibizumab; Scleral Diseases; Vascular Endothelial Growth Factor A | 2016 |
Necrotizing Thrombophlebitis Secondary to Mycobacterium Chelonae in a Hemodialyzed Patient.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Biopsy, Needle; Clarithromycin; Drug Therapy, Combination; Humans; Immunohistochemistry; Kidney Failure, Chronic; Male; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Necrosis; Prognosis; Renal Dialysis; Severity of Illness Index; Thrombophlebitis; Treatment Outcome | 2017 |
Failure of the Amikacin, Cefoxitin, and Clarithromycin Combination Regimen for Treating Pulmonary Mycobacterium abscessus Infection.
Topics: Amikacin; Anti-Bacterial Agents; Cefoxitin; Clarithromycin; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Treatment Failure | 2016 |
Selection of Resistance to Clarithromycin in Mycobacterium abscessus Subspecies.
Topics: Amikacin; Anti-Bacterial Agents; Cefoxitin; Ciprofloxacin; Clarithromycin; Imipenem; Linezolid; Microbial Sensitivity Tests; Minocycline; Mutation; Mycobacterium; Tigecycline | 2017 |
Antagonism between Front-Line Antibiotics Clarithromycin and Amikacin in the Treatment of Mycobacterium abscessus Infections Is Mediated by the
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Proteins; Clarithromycin; Drug Antagonism; Drug Resistance, Multiple, Bacterial; Gene Expression Regulation, Bacterial; Humans; Microbial Sensitivity Tests; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous | 2017 |
Antimicrobial resistance in Mycobacterium abscessus complex isolated from patients with skin and soft tissue infections at a tertiary teaching hospital in Taiwan.
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Proteins; Clarithromycin; Drug Resistance, Bacterial; High-Throughput Nucleotide Sequencing; Hospitals, Teaching; Humans; Microbial Sensitivity Tests; Minocycline; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Skin; Skin Diseases, Bacterial; Soft Tissue Infections; Taiwan; Tertiary Care Centers; Tigecycline | 2017 |
In vitro activity of tedizolid against the Mycobacterium abscessus complex.
Topics: Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Drug Combinations; Drug Resistance, Multiple, Bacterial; Humans; Linezolid; Microbial Sensitivity Tests; Minocycline; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Oxazolidinones; Tetrazoles; Tigecycline | 2018 |
Influence of three-dimensional lung epithelial cells and interspecies interactions on antibiotic efficacy against Mycobacterium abscessus and Pseudomonas aeruginosa.
Topics: Amikacin; Anti-Bacterial Agents; Biofilms; Ceftazidime; Cell Culture Techniques; Clarithromycin; Colistin; Drug Resistance, Bacterial; Epithelial Cells; Host-Pathogen Interactions; Humans; Lung; Microbial Interactions; Microbial Sensitivity Tests; Mycobacterium abscessus; Pseudomonas aeruginosa; Species Specificity | 2018 |
Clinical, Radiological, and Microbiological Characteristics of Mycobacterium simiae Infection in 97 Patients.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Clarithromycin; Female; Fluoroquinolones; Humans; Lung; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Retrospective Studies; Reunion | 2018 |
Chronic otitis media caused by Mycobacterium abscessus spp. massiliense treated with tigecycline in a 10-year-old child.
Topics: Amikacin; Anti-Bacterial Agents; Child; Chronic Disease; Clarithromycin; Humans; Male; Microbial Sensitivity Tests; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Otitis Media; Tigecycline; Tokyo | 2018 |
Genetic Correlation of Antibiotic Susceptibility and Resistance Genotyping for the
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Proteins; Clarithromycin; Drug Resistance, Multiple, Bacterial; Genotype; Humans; Microbial Sensitivity Tests; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous | 2019 |
Analysis of drug-susceptibility patterns and gene sequences associated with clarithromycin and amikacin resistance in serial Mycobacterium abscessus isolates from clinical specimens from Northeast Thailand.
Topics: Amikacin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Sequence Analysis, DNA; Thailand | 2018 |
Mycobacterium brisbanense lung infection facilitated by steroid induced adrenal insufficiency.
Topics: Adrenal Insufficiency; Adult; Amikacin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Humans; Male; Moxifloxacin; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Respiratory Tract Infections; Sputum | 2019 |
Tetrahydropyridine derivative as efflux inhibitor in Mycobacterium abscessus.
Topics: Amikacin; Anti-Bacterial Agents; Biological Transport; Ciprofloxacin; Clarithromycin; Humans; Microbial Sensitivity Tests; Mycobacterium abscessus; Pyrrolidines; Verapamil | 2019 |
Postoperative Mycobacteroides abscessus subsp. abscessus endophthalmitis: Clinical analysis of 12 clustered adults and a proposed therapeutic algorithm.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Algorithms; Amikacin; Anti-Bacterial Agents; Clarithromycin; Endophthalmitis; Eye; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Postoperative Complications; Taiwan; Vitrectomy; Young Adult | 2020 |
Mycobacterium abscessus urinary tract infection: case report.
Topics: Amikacin; Anti-Bacterial Agents; Clarithromycin; Follow-Up Studies; Humans; Male; Middle Aged; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Treatment Outcome; Urinary Tract Infections | 2020 |
Rare case of pacemaker infection with
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Arrhythmias, Cardiac; Cefoxitin; Clarithromycin; Clofazimine; Drug Resistance, Bacterial; Epidural Abscess; Heroin Dependence; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Osteomyelitis; Pacemaker, Artificial; Prosthesis-Related Infections | 2019 |
In vitro efficacy of combinations of eight antimicrobial agents against Mycobacteroides abscessus complex.
Topics: Actinomycetales Infections; Amikacin; Anti-Bacterial Agents; beta-Lactams; Clarithromycin; Doxycycline; Humans; Imipenem; Linezolid; Microbial Sensitivity Tests; Moxifloxacin; Mycobacteriaceae; Sequence Analysis, DNA | 2020 |
Different clinical features of patients with pulmonary disease caused by various Mycobacterium avium-intracellulare complex subspecies and antimicrobial susceptibility.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Female; Humans; Lung Diseases; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Mycobacterium avium; Mycobacterium avium-intracellulare Infection; Taiwan; Young Adult | 2020 |
Evaluation of the GenoType NTM-DR assay performance for the identification and molecular detection of antibiotic resistance in Mycobacterium abscessus complex.
Topics: Amikacin; Anti-Bacterial Agents; Clarithromycin; DNA Mutational Analysis; DNA, Bacterial; Drug Resistance, Bacterial; Genes, Bacterial; Genotyping Techniques; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Mutation; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Polymerase Chain Reaction; Reagent Kits, Diagnostic | 2020 |
The synergetic effect of Imipenem-clarithromycin combination in the Mycobacteroides abscessus complex.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Clarithromycin; Drug Combinations; Drug Synergism; Female; Humans; Imipenem; Japan; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous | 2020 |
Microbiology of secondary infections in Buruli ulcer lesions; implications for therapeutic interventions.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Bacillus; Bacteria; Buruli Ulcer; Candida; Clarithromycin; Coinfection; Cote d'Ivoire; Cross-Sectional Studies; Female; Fungi; Ghana; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Penicillium; Staphylococcus; Streptomycin; Trichoderma; Watchful Waiting; Young Adult | 2021 |
Comparison of two-drug combinations, amikacin/tigecycline/imipenem and amikacin/tigecycline/clarithromycin against Mycobacteroides abscessus subsp. abscessus using the in vitro time-kill assay.
Topics: Amikacin; Anti-Bacterial Agents; Clarithromycin; Colony Count, Microbial; Drug Combinations; Humans; Imipenem; Microbial Sensitivity Tests; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Tigecycline | 2021 |
Pneumonia due to
Topics: Aged; Amikacin; Clarithromycin; Humans; Kidney Transplantation; Male; Mycobacteriaceae; Mycobacterium Infections, Nontuberculous | 2021 |
Drug susceptibiity testing of nontuberculous mycobacteria by broth microdilution method.
Topics: Amikacin; Anti-Bacterial Agents; Clarithromycin; Humans; India; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Rifampin | 2021 |
Nationwide surveillance of antimicrobial susceptibility of 509 rapidly growing mycobacteria strains isolated from clinical specimens in Japan.
Topics: Amikacin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Humans; Japan; Linezolid; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria | 2021 |
Clinical Whole Genome Sequencing for Clarithromycin and Amikacin Resistance Prediction and Subspecies Identification of Mycobacterium abscessus.
Topics: Amikacin; Anti-Bacterial Agents; Clarithromycin; Clinical Laboratory Techniques; Drug Resistance, Multiple, Bacterial; Humans; Laboratories, Clinical; Microbial Sensitivity Tests; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Phylogeny; Polymorphism, Single Nucleotide; Prognosis; RNA, Ribosomal, 16S; Whole Genome Sequencing | 2021 |
[Mycobacterium abscessus, a model of resistance to multiple antibiotic classes].
Topics: Amikacin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous | 2021 |
Rapid Detection of Clarithromycin and Amikacin Resistance in Mycobacterium abscessus Complex by High-Resolution Melting Curve Analysis.
Topics: Amikacin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous | 2022 |
Identification and drug susceptibility testing of the subspecies of Mycobacterium avium complex clinical isolates in mainland China.
Topics: Amikacin; Clarithromycin; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Mycobacterium tuberculosis; Rifabutin | 2022 |
In vitro assessment of 17 antimicrobial agents against clinical Mycobacterium avium complex isolates.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Clofazimine; Humans; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifabutin | 2022 |
Drug susceptibility profiling and genetic determinants of drug resistance in Mycobacterium simiae isolates obtained from regional tuberculosis reference laboratories of Iran.
Topics: Amikacin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance; Humans; Iran; Laboratories; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium; Mycobacterium Infections, Nontuberculous; Mycobacterium tuberculosis; Nontuberculous Mycobacteria; Tuberculosis | 2022 |
Outcomes of Nontuberculous Mycobacterial Keratitis After Clear Corneal Incision Phacoemulsification Surgery: A Case Series of 6 Eyes in South Florida.
Topics: Abscess; Amikacin; Azithromycin; Clarithromycin; Eye Infections, Bacterial; Florida; Humans; Keratitis; Mycobacterium Infections, Nontuberculous; Phacoemulsification | 2022 |
Unraveling antibiotic resistance mechanisms in Mycobacterium abscessus: the potential role of efflux pumps.
Topics: Amikacin; Anti-Bacterial Agents; Cefoxitin; Clarithromycin; Clofazimine; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Mycobacterium abscessus; Thioridazine; Tigecycline; Verapamil | 2022 |
[The Importance of Gram-stained Smears in the Diagnosis of Nocardia Infections].
Topics: Amikacin; Anti-Bacterial Agents; Cefepime; Cefotaxime; Ceftriaxone; Ciprofloxacin; Clarithromycin; Humans; Imipenem; Linezolid; Nocardia; Nocardia Infections; RNA, Ribosomal, 16S; Trimethoprim, Sulfamethoxazole Drug Combination | 2023 |
[Evaluation of Antimicrobial Susceptibilities of Rapidly Growing Mycobacteria].
Topics: Amikacin; Anti-Bacterial Agents; Cefoxitin; Ciprofloxacin; Clarithromycin; Doxycycline; Humans; Imipenem; Linezolid; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Tobramycin | 2023 |
Secondary Mycobacterium abscessus Infection after Debridement in Child with Dog Bite: a Case Report.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Child, Preschool; Clarithromycin; Debridement; Dogs; Female; Humans; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous | 2023 |
The potential role of drug transporters and amikacin modifying enzymes in M. avium.
Topics: Amikacin; Anti-Bacterial Agents; ATP-Binding Cassette Transporters; Berberine; Clarithromycin; Ethambutol; Humans; Membrane Transport Proteins; Mycobacterium avium; Mycobacterium avium Complex; Mycobacterium tuberculosis | 2023 |
Clinical characteristics and drug susceptibility profiles of Mycobacterium abscessus complex infection at a medical school in Thailand.
Topics: Amikacin; Anti-Infective Agents; Clarithromycin; Humans; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Schools, Medical; Thailand | 2023 |
Aortic endograft infection by Mycobacterium abscessus subsp. massiliense with acquired clarithromycin resistance: a case report.
Topics: Abscess; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Cilastatin, Imipenem Drug Combination; Clarithromycin; Drug Resistance, Bacterial; Humans; Macrolides; Male; Microbial Sensitivity Tests; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Stents | 2023 |
In vitro susceptibility patterns for slowly growing non-tuberculous mycobacteria in the USA from 2018 to 2022.
Topics: Amikacin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria | 2023 |
Phenotypic drug-susceptibility profiles and genetic analysis based on whole-genome sequencing of Mycobacterium avium complex isolates in Thailand.
Topics: Amikacin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Humans; Linezolid; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Phylogeny; Thailand | 2023 |